Henry Waxman said...
The PCAST report's fourth recommendation is the creation of a new pathway that manufacturers could choose to use for initial approval of drugs shown to be safe and effective in a specific subgroup of patients.
Context
Waxman discusses a recommendation for a new drug approval pathway for specific patient subgroups.
05/19/2014